Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

OBJECTIVES: To address the uncertainty associated with procuring pharmaceutical products, product listing agreements (PLAs) are increasingly being used to support responsible funding decisions in Canada and elsewhere. These agreements typically involve financial-based rebating initiatives or, less f...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Melissa, Henshall, Chris, Garrison, Louis P, Griffin, Adrian D, Coyle, Doug, Long, Stephen, Khayat, Zayna A, Anger, Dana L, Yu, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008446/
https://www.ncbi.nlm.nih.gov/pubmed/27616892
http://dx.doi.org/10.2147/CEOR.S96616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008446/
https://www.ncbi.nlm.nih.gov/pubmed/27616892
http://dx.doi.org/10.2147/CEOR.S96616

Ejemplares similares